Press Release

Earvin "Magic" Johnson and Abbott Bring "I Stand with Magic" Program: Part of the Campaign to End Black HIV/AIDS to Facebook Community

June 27, 2008

Abbott Park, Illinois (NYSE: ABT)


Article tools:
RSS      

Related Links:
  Magic Johnson Foundation
  "I Stand with Magic"
  "I Stand with Magic" Facebook Group
  "Stand" PSA
  "Talk" PSA
  HIV/AIDS and Abbott

Summary

"I Stand With Magic" PSAs Directed by Spike Lee

In addition to providing information on HIV/AIDS, testing resources and upcoming events, the Facebook group features the new public service announcements (PSAs) directed by Academy Award-nominated director Spike Lee.

"I Stand With Magic Program," Part of the " Campaign to End Black HIV/AIDS"

The "I Stand With Magic" program focuses on African-American and other minority communities where new HIV infections are increasingly prevalent. About half of all new HIV infections in the United States are among African Americans, who represent about 13 percent of the population.

Quotes

Scott Luce
Divisional Vice President, Pharmaceutical Specialty Operations, Abbott

"The 'I Stand With Magic' Facebook group is an exciting new endeavor for the program and furthers our efforts to empower others to take a stand and help combat this epidemic. National HIV Testing Day reminds us of how important it is for communities everywhere to encourage friends and family to get tested and seek treatment."

HIV/AIDS in the United States

About the Magic Johnson Foundation

The Magic Johnson Foundation was established in 1991 as a single-disease organization that works to raise funds for community-based organizations dealing with HIV/AIDS education and prevention programs.

The Foundation has since responded to the growing need to address all aspects of our youth's lives by expanding its mission. This expanded mission emphasizes the Foundation's focus on supporting community-based organizations and development programs that serve the health, educational and social needs of those residing in minority communities.

Video:

Additional Resources:

About Abbott

Abbott has been a leader in HIV/AIDS research since the early years of the epidemic. In 1985, the company developed the first licensed test to detect HIV antibodies in the blood and remains a leader in HIV diagnostics. Abbott retroviral and hepatitis tests are used to screen more than half of the world's donated blood supply. Abbott has developed two protease inhibitors for the treatment of HIV.

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

 

Media:
Julie Herlocker

(847) 936-6116

Top